AR and prostate carcinoma: Moreover, these compounds were biologically tested for their cytotoxic effects against androgen-sensitive (AR+LNCaP) and androgen-insensitive (AR-PC-3) human prostate cancer cell lines, in addition to normal human lung fibroblast (Wi38) as control.